PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
2026-08-19T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
2026-08-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence
2026-08-18T    Biotechnology   Medical/Pharmaceuticals 
Enginprime Medical Closes $12M Series A Financing
2026-08-18T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture
2026-08-17T    Health Care/Hospital   Medical/Pharmaceuticals 
U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting
2026-08-17T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths
2026-08-17T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
2026-08-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech Announces 2026 Interim Results
2026-08-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
2026-08-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.